StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$305.06−5.21 (-1.68%)

Close on Nov 17, 2026Market cap $8.52BP/E –Yield –

Praxis Precision Medicines price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Praxis Precision Medicines's price to sales ratio was 143.6× on Sep 30, 2025, against 219.2× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Sep 30, 2025143.6×−205.0
2024Jul 31, 2024348.6×+249.7
2023Dec 29, 202398.8×–

More Praxis Precision Medicines figures

See a number that looks wrong?